Evidence map›Paper›PMID 28808775›Full record

ReviewSeminars in immunopathology2018

How novel structures inform understanding of complement function.

Elena Goicoechea de Jorge, Hugo Yebenes, Marina Serna, Agustín Tortajada, Oscar Llorca, Santiago Rodríguez de Córdoba

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elena Goicoechea de JorgeDepartment of Microbiology I (Immunology), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Hugo YebenesCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Marina SernaCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Agustín TortajadaDepartment of Microbiology I (Immunology), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Oscar LlorcaCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Santiago Rodríguez de CórdobaCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040, Madrid, Spain. srdecordoba@cib.csic.es.ORCID 0000-0001-6401-1874
Consejo Superior de Investigaciones Científicas · ES

Funding

Autonomous Region of Madrid S2010/BMD-2316Ministerio de Economia y Competitividad IJCI-2015-24388Ministerio de Economia y Competitividad IJCI-2015-25222Ministerio de Economia y Competitividad SAF2014-52339PMinisterio de Economía y Competitividad RYC-2013-13395Ministerio de Economía y Competitividad SAF2015-66287RSeventh Framework Programme European Union Project EURen Omics 305608Spanish Ministry of Economy, Industry and Competitiveness SAF2014-52301-R
6 · The paper itself

Abstract

During the last decade, the complement field has experienced outstanding advancements in the mechanistic understanding of how complement activators are recognized, what C3 activation means, how protein complexes like the C3 convertases and the membrane attack complex are assembled, and how positive and negative complement regulators perform their function. All of this has been made possible mostly because of the contributions of structural biology to the study of the complement components. The wealth of novel structural data has frequently provided support to previously held knowledge, but often has added alternative and unexpected insights into complement function. Here, we will review some of these findings focusing in the alternative and terminal complement pathways.

Indexed as

AnimalsCarrier ProteinsComplement ActivationComplement C3-C5 ConvertasesComplement System ProteinsHost-Pathogen InteractionsHumansProtein BindingProtein ConformationSignal TransductionStructure-Activity RelationshipSubstrate SpecificityCarrier ProteinsComplement C3-C5 ConvertasesComplement System ProteinsC3\C5 convertaseComplementComplement regulatorsFactor HMembrane attack complexStructural biology

Identifiers

PMID28808775
OpenAlexW2746136783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.